Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age-Related Macular Degeneration (ARMD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01233115
What this trial is testing

LOC387715/HTRA1 and the Combined Photodynamic Therapy With Intravitreal Bevacizumab in Polypoidal Choroidal Vasculopathy

Who this might be right for
Age-Related Macular Degeneration
Kyungpook National University Hospital 70
Post-approval studies (Phase 4)Study completedNCT02305238
What this trial is testing

Japanese Treat and Extend Study of Aflibercept in Neovascular Age-related Macular Degeneration

Who this might be right for
Wet Macular Degeneration
Bayer 288
Large-scale testing (Phase 3)WithdrawnNCT03784443
What this trial is testing

Combined Ranibizumab and Iluvien for Diabetic Macular Oedema

Who this might be right for
Diabetic Macular EdemaDiabetes
Imperial College London
Post-approval studies (Phase 4)Study completedNCT04679935
What this trial is testing

Efficacy and Safety of Two Different Brolucizumab 6 mg Dosing Regimens in Neovascular Age-related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Novartis Pharmaceuticals 52
Not applicableStudy completedNCT05324150
What this trial is testing

M Charts Versus Amsler Test in Evaluating Metamorphopsia in nAMD

Who this might be right for
Macular Degeneration, WetMetamorphopsia
Ospedale Santa Croce-Carle Cuneo 57
Not applicableStudy completedNCT03956797
What this trial is testing

Long Term Safety of Cooling Anesthesia for Intravitreal Injection

Who this might be right for
Anesthesia, LocalIntravitreal InjectionMacular Edema+3 more
Recens Medical, Inc. 80
Large-scale testing (Phase 3)Study completedNCT05536297
What this trial is testing

Avacincaptad Pegol Open-Label Extension for Patients With Geographic Atrophy

Who this might be right for
Geographic AtrophyAge-Related Macular Degeneration
Astellas Pharma Global Development, Inc. 278
Not applicableStudy completedNCT01447043
What this trial is testing

Study to Assess the Effectiveness of Existing Anti vascUlar Endothelial Growth Factor (Anti VEGF) in Patients With Wet Age-related Macular Degeneration (wAMD) (AURA)

Who this might be right for
Ophthalmology, Macular Degeneration
Bayer 2,609
Not applicableStudy completedNCT00460408
What this trial is testing

Ocular Safety Of Patients Receiving Macugen For Neovascular Age Related Macular Degeneration

Who this might be right for
Macular Degeneration
Pfizer 501
Post-approval studies (Phase 4)Ended earlyNCT02665689
What this trial is testing

Influence of Diabetes Control on Treatment of Diabetic Macular Edema With Ranibizumab

Who this might be right for
Visual Acuity Reduced TransientlyMacular Edema, Cystoid
Prof. Dr. Antonia M. Joussen 4
Testing effectiveness (Phase 2)Study completedNCT01134055
What this trial is testing

Dose Ranging Study of Pazopanib to Treat Neovascular Age-Related Macular Degeneration

Who this might be right for
Macular Degeneration
GlaxoSmithKline 510
Not applicableUnknownNCT03433885
What this trial is testing

Wenzhou Dry Age-related Macular Degeneration (AMD) Progression Study

Who this might be right for
Macular Pigment Optical Density
The Eye Hospital of Wenzhou Medical University 300
Not applicableStudy completedNCT02313259
What this trial is testing

The Impact of Ocular Diseases on Driving: a Prospective Study

Who this might be right for
Macular DegenerationGlaucoma
CHU de Quebec-Universite Laval 60
Testing effectiveness (Phase 2)Study completedNCT00344227
What this trial is testing

Prospective OCT Study With Lucentis for Neovascular AMD (PrONTO Study)

Who this might be right for
Neovascular Age-Related Macular Degeneration
University of Miami 40
Large-scale testing (Phase 3)Study completedNCT00215670
What this trial is testing

Study of the Safety, Tolerability and Pharmacokinetics of 1 Mg/Eye and 3 Mg/Eye Pegaptanib Sodium in Patients With Exudative Age-Related Macular Degeneration (AMD)

Who this might be right for
Age-Related Macular Degeneration
Eyetech Pharmaceuticals 125
Post-approval studies (Phase 4)Study completedNCT02120950
What this trial is testing

Aflibercept in Polypoidal Choroidal Vasculopathy

Who this might be right for
Neovascular Macular Degeneration
Bayer 333
Post-approval studies (Phase 4)Ended earlyNCT00566761
What this trial is testing

Treatment of Bevacizumab and Triamcinolone in Treatment or Macular Edema Secondary to CRVO

Who this might be right for
Macular EdemaCentral Retinal Vein Occlusion
Asociación para Evitar la Ceguera en México 10
Testing effectiveness (Phase 2)Ended earlyNCT00114062
What this trial is testing

Study to Treat Uveitis Associated Macular Edema

Who this might be right for
Cystoid Macular EdemaUveitis
Merck Sharp & Dohme LLC 15
Testing effectiveness (Phase 2)Study completedNCT01849692
What this trial is testing

ESBA1008 Microvolume Study

Who this might be right for
Exudative Age-Related Macular Degeneration
Alcon Research 107
Post-approval studies (Phase 4)Looking for participantsNCT06875245
What this trial is testing

Comparing Efficacy of 8-Week and 12-Week Faricimab Initial Follow-Up Treatment Intervals

Who this might be right for
Wet Age-related Macular Degeneration
Faculty Hospital Kralovske Vinohrady 100
Next Page